✦ LIBER ✦

Safety biomarkers: Opportunities and challenges in drug discovery and development

✍ Scribed by Ina Schuppe-Koistinen

Book ID: 116925024
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 42 KB
Volume: 211
Category: Article
ISSN: 0378-4274
DOI: 10.1016/j.toxlet.2012.03.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Opportunities and Challenges in Antipara

Opportunities and Challenges in Antiparasitic Drug Discovery

✍ Pink, Richard; Hudson, Alan; Mouriès, Marie-Annick; Bendig, Mary 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 348 KB

Challenges and opportunities for oncolog

Challenges and opportunities for oncology biomarker discovery

✍ Deyati, Avisek; Younesi, Erfan; Hofmann-Apitius, Martin; Novac, Natalia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 647 KB

Biomarkers in drug discovery and develop

Biomarkers in drug discovery and development

✍ Ray Bakhtiar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Multiscale Modeling in Drug Discovery an

Multiscale Modeling in Drug Discovery and Development: Future Opportunities and Present Challenges

✍ Vicini, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Clinical biomarkers in drug discovery an

Clinical biomarkers in drug discovery and development

✍ Frank, Richard; Hargreaves, Richard 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 841 KB

Proteomics in biomarker discovery and dr

Proteomics in biomarker discovery and drug development

✍ Qing-Yu He; Jen-Fu Chiu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Abstract Proteomics is a research field aiming to characterize molecular and cellular dynamics in protein expression and function on a global level. The introduction of proteomics has been greatly broadening our view and accelerating our path in various medical researches. The most significant a